Primary Peritoneal Carcinoma Active Not Recruiting Phase 1 / 2 Trials for Fenretinide (DB05076)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01535157Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian CancerTreatment